Skip to main content
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.360
+0.140 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
4.510
+0.150 (3.44%)
After-hours: Mar 9, 2026, 7:35 PM EDT

Cytek Biosciences Revenue

In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth. Cytek Biosciences had revenue of $62.14M in the quarter ending December 31, 2025, with 8.12% growth.

Revenue (ttm)
$201.49M
Revenue Growth
+0.52%
P/S Ratio
2.78
Revenue / Employee
$287,027
Employees
702
Market Cap
560.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025201.49M1.04M0.52%
Dec 31, 2024200.45M7.44M3.85%
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 854.40M
Orthofix Medical 822.31M
Avanos Medical 701.20M
Bioventus 568.09M
Tactile Systems Technology 329.52M
OrthoPediatrics 236.35M
SI-BONE 200.93M
Beta Bionics 100.25M
Revenue Rankings

CTKB News

More News